National Taiwan University is focusing on prevention in dormitories to keep COVID-19 cluster infections under control. According to a recent UK study, seniors should get their second vaccine dose as soon as possible.
Students are heading back to school with the fall semester opening. National Taiwan University’s College of Public Health recently compared Taiwan’s prevention methods with other countries. Both the US and Europe are vaccinating children between the ages of 12 and 18 and continuing with blended learning to lower the risk of cluster infections.
According to one UK research report, college freshmen are a major source of infection on campuses, which makes dormitories a key cog in prevention.
Chen Hsiu-his, Public Health Professor, National Taiwan University:” One of our priorities is preventing cluster infections in dorms, and students are for the most part cooperating. As for so-called remote learning, that is something we should consider.”
Israel is the first country in the world to give third booster shots to everyone over 12. Chen Hsiu-hsi says this will detrimentally affect the global vaccine supply. According to a new UK study of medical personnel and long-term care facility residents that received AZ and BNT vaccines, seniors had reduced viral suppression abilities after getting one shot. The study recommended that seniors that have not had COVID-19 to get their second shot as soon as possible.
Lai Chao-chih, ER Doctor, Taipei Hospital Renai Branch:” (Seniors) that have only gotten one dose will see their serum antibody levels go down very quickly after a certain amount of time. (One dose) isn’t enough to fight off these viral infections. So, the conclusion of this report is that (seniors) should get their second dose as soon as possible.”
Some countries won’t let people get a second shot in order to increase the first-dose coverage rate. The appropriateness of this kind of policy for seniors is in question. The UK study also showed that BNT provided slightly higher neutralizing antibody protection five to six weeks after a first dose than AZ. The T-cell response, however, was three times higher with AZ.
The report also said the two vaccines provide equal protection to those that have had COVID-19.